Nogara Leonardo, Germani Serena, De Napoli Cosimo, Blaauw Bert, Zito Ester
Department of Biomedical Sciences, University of Padua, Padua, Italy; Department of Pharmaceutical Sciences, University of Padua, Padua, Italy.
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
STAR Protoc. 2025 Jun 26;6(3):103918. doi: 10.1016/j.xpro.2025.103918.
Selenoprotein N1 (SEPN1) is a type II endoplasmic reticulum (ER) glycoprotein. Loss-of-function mutations in the gene encoding for SEPN1 give rise to myopathy. Here, we present a protocol for evaluating the contractility of diaphragmatic muscle fibers of SEPN1 knockout mice following chronic treatment with tauroursodeoxycholic acid (TUDCA). We describe steps for genotyping SEPN1 knockout mice, TUDCA in vivo treatment, diaphragm dissection, and chemical permeabilization. We then detail procedures for single muscle fiber isolation and tension measurement. For complete details on the use and execution of this protocol, please refer to Germani et al..
硒蛋白N1(SEPN1)是一种II型内质网(ER)糖蛋白。编码SEPN1的基因功能缺失突变会导致肌病。在此,我们展示了一种用于评估经牛磺熊去氧胆酸(TUDCA)长期治疗后的SEPN1基因敲除小鼠膈肌纤维收缩性的方案。我们描述了对SEPN1基因敲除小鼠进行基因分型、TUDCA体内治疗、膈肌解剖以及化学通透处理的步骤。然后我们详细说明了单根肌纤维分离和张力测量的程序。有关此方案的使用和执行的完整详细信息,请参考Germani等人的研究。